Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: Longitudinal analyses from the randomized phase III ExteNET trial

  1. Delaloge, S.
  2. Cella, D.
  3. Ye, Y.
  4. Buyse, M.
  5. Chan, A.
  6. Barrios, C.H.
  7. Holmes, F.A.
  8. Mansi, J.
  9. Iwata, H.
  10. Ejlertsen, B.
  11. Moy, B.
  12. Chia, S.K.L.
  13. Gnant, M.
  14. Smichkoska, S.
  15. Ciceniene, A.
  16. Martinez, N.
  17. Filipović, S.
  18. Ben-Baruch, N.E.
  19. Joy, A.A.
  20. Langkjer, S.T.
  21. Senecal, F.
  22. De Boer, R.H.
  23. Moran, S.
  24. Yao, B.
  25. Bryce, R.
  26. Auerbach, A.
  27. Fallowfield, L.
  28. Martin, M.
  29. Montrer des auteurs +
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2019

Volumen: 30

Número: 4

Pages: 567-574

Type: Article

DOI: 10.1093/ANNONC/MDZ016 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus